Surgery represents the only chance of cure for a patient with a neuroendocrine tumour (NET). The main indications for surgery lie in the risk of developing metastatic disease with increasing tumour diameter and for a functioning NET also in control of the hormonal syndrome. However, only a small minority of patients presents with a potentially resectable primary NET without metastatic disease. An R0-resection is mandatory, which may be achieved in selected cases by tissue sparing surgical techniques. Most patients unfortunately present with a locally advanced or metastatic disease. For patients with an advanced functioning NET, control of the hormonal syndrome may also represent a surgical indication. Various cytoreductive techniques or, in...
BACKGROUND Esophageal neuroendocrine tumors (eNETs) are exceedingly rare, aggressive and have a p...
Abstract. There has been a rising trend in the incidence and prevalence of non-functioning pancreati...
Neuroendocrine tumors are divided into gastrointestinal carcinoids and pancreatic neuroendocrine tum...
Surgery represents the only chance of cure for a patient with a neuroendocrine tumour (NET). The mai...
Introduction: Neuroendocrine tumors originate from chromaffin-like cells and are tumors with neuroe...
Neuroendocrine tumors (NET) are a rare and heterogeneous group of neoplasms with variable biological...
Summary Neuroendocrine tumor (NET) metastases represent at this moment the only accepted indication ...
Copyright © 2013 Daniela Macedo et al. This is an open access article distributed under the Creative...
Neuroendocrine neoplasms (NENs) are a distinctive entity, and nearly 10% of patients already have li...
The prevalence of metastatic disease in neuroendocrine tumors (NETs) is very high (60-80%) and cance...
Neuroendocrine tumours (NETs) are very rare diseases characterised by a high degree of histological ...
Abstract Neuroendocrine tumours (NET) frequently meta-stasise to the liver (NLM) and are associated ...
INTRODUCTION: Neuroendocrine tumors (NETs) are a heterogeneous group of tumors. NET of colon represe...
Neuroendocrine tumours (NETs) represent a group of neoplasias characterized by significant histopath...
Objective: Gastroenteropancreatic neuroendocrine tumor disease has a low incidence of 5 pr 100 000 a...
BACKGROUND Esophageal neuroendocrine tumors (eNETs) are exceedingly rare, aggressive and have a p...
Abstract. There has been a rising trend in the incidence and prevalence of non-functioning pancreati...
Neuroendocrine tumors are divided into gastrointestinal carcinoids and pancreatic neuroendocrine tum...
Surgery represents the only chance of cure for a patient with a neuroendocrine tumour (NET). The mai...
Introduction: Neuroendocrine tumors originate from chromaffin-like cells and are tumors with neuroe...
Neuroendocrine tumors (NET) are a rare and heterogeneous group of neoplasms with variable biological...
Summary Neuroendocrine tumor (NET) metastases represent at this moment the only accepted indication ...
Copyright © 2013 Daniela Macedo et al. This is an open access article distributed under the Creative...
Neuroendocrine neoplasms (NENs) are a distinctive entity, and nearly 10% of patients already have li...
The prevalence of metastatic disease in neuroendocrine tumors (NETs) is very high (60-80%) and cance...
Neuroendocrine tumours (NETs) are very rare diseases characterised by a high degree of histological ...
Abstract Neuroendocrine tumours (NET) frequently meta-stasise to the liver (NLM) and are associated ...
INTRODUCTION: Neuroendocrine tumors (NETs) are a heterogeneous group of tumors. NET of colon represe...
Neuroendocrine tumours (NETs) represent a group of neoplasias characterized by significant histopath...
Objective: Gastroenteropancreatic neuroendocrine tumor disease has a low incidence of 5 pr 100 000 a...
BACKGROUND Esophageal neuroendocrine tumors (eNETs) are exceedingly rare, aggressive and have a p...
Abstract. There has been a rising trend in the incidence and prevalence of non-functioning pancreati...
Neuroendocrine tumors are divided into gastrointestinal carcinoids and pancreatic neuroendocrine tum...